The DOI matches its Crossref record.
Fear of Cancer Recurrence Therapy (FORT): A Randomized Controlled Trial
Open accessAbstract
Objective: Most fear of cancer recurrence (FCR) interventions have small effects, and few target FCR. This randomized controlled trial (RCT) with breast and gynecological cancer survivors evaluated the efficacy of a cognitive-existential fear of recurrence therapy (FORT) compared to an attention placebo control group (living well with cancer [LWWC]) on FCR. Method: One hundred and sixty-four women with clinical levels of FCR and cancer distress were randomly assigned to 6-weekly, 120 min FORT (n= 80) or LWWC (n= 84) group sessions. They completed questionnaires at baseline (T1), posttreatment (T2; primary endpoint), 3 (T3), and 6 months (T4) posttreatment. Generalized linear models were used to compare group differences in the fear of cancer recurrence inventory (FCRI) total score and secondary outcomes. Results: FORT participants experienced greater reductions from T1 to T2 on FCRI total with a between-group difference of−9.48 points ( p=.0393), resulting in a medium effect of−0.530, with a maintained effect at T3 ( p=.0330) but not at T4. For the secondary outcomes, improvements were in favor of FORT, including FCRI triggers ( p=.0208), FCRI coping ( p=.0351), cognitive avoidance ( p=.0155), need for reassurance from physicians ( p=.0117), and quality of life (mental health; p=.0147). Conclusions: This RCT demonstrated that FORT, compared to an attention placebo control group, resulted in a greater reduction in FCR posttreatment and at 3 months posttreatment in women with breast and gynecological cancer, indicating its potential as a new treatment strategy. We recommend a booster session to sustain gains © 2023 American Psychological Association
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Cancer survivors in the experimental arm experienced FCR reductions five times greater than those in the control group (moderate effect size; d = − 0.53) [44].”
In the citing paper
“The Fear Of Recurrence Therapy (FORT) is a standardized and manualized intervention that consists of six consecutive weekly sessions [43–45].”
In the citing paper
“In addition, compared to the control group, the experimental arm experienced significant decreases in secondary outcomes [triggers, (d = − 0.415), coping (d = − 0.244), cognitive avoidance (d = − 0.424), QoL mental health (d = 0.165)], with sustained improvements at the 3-month follow up.”
In the citing paper
“A large multisite RCT of FORT was subsequently completed with 136 women cancer survivors who were either randomized to FORT or a structurally equivalent support group.”
In the citing paper
“FORT’s pilot [43] and RCT [44, 46] studies demonstrated good questionnaire completion rates.”
Citations
Cited by
Lamarche, J., Cusson, A., Nissim, R., Avery, J., Wong, J., Maheu, C., Lambert, S. D., Laizner, A. M., Jones, J., Esplen, M. J., et al. (2023) · Frontiers in Digital Health · doi:10.3389/fdgth.2023.1129536 · Cited by 18
“Frontiers in Digital Health 03 (40) with sustained improvements at a 3-month follow up.”
BackgroundSelf-citationSmith, A. B., Girgis, A., Taylor, N. J., Pearce, A. M., Liu, J., Shepherd, H. L., Wu, V. S., Garvey, G., Kirsten, L. T., Zakhary, I., et al. (2024) · Journal of Cancer Survivorship · doi:10.1007/s11764-024-01685-1 · Cited by 19
Maheu, C., Tock, W. L., Fisher, P., Galica, J., Singh, M. D., Centeno, I., Hébert, M., Moran, C., Pietruczuk, P., Dinkel, A., et al. (2025) · Healthcare · doi:10.3390/healthcare13172165 · Cited by 15
“Although the published version specified a 0–100 format, respondents were also permitted to use a 0–10 scale if preferred—a detail clarified through personal communication with the lead author of the FORT randomized controlled trial [56], which provided the validation data.”
InfluentialSelf-citationTutelman, P. R., Moran, C., Beattie, S., Khu, M., Howlett, M., Scheidl, J., Boychuk, A., Silveira, K., Henning, J., & Schulte, F. (2024) · Psycho-Oncology · doi:10.1002/pon.6335 · Cited by 12
“First, potential session topics were identified based on existing protocols, 14,17 review of AYA psychosocial needs and clinical practice guidelines, 18–20 and clinical experience.”
BackgroundMethodAguiar‐Ibáñez, R., Mbous, Y. P. V., Sharma, S., Chawla, E., & Pawar, D. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1575813 · Cited by 12
Metadata
- Authors
- Maheu, C., Lebel, S., Bernstein, L. J., Courbasson, C., Singh, M., Ferguson, S. E., Harris, C., Jolicoeur, L., Baku, L., Muraca, L., Ramanakumar, A. V., Lamonde, F., Lefebvre, M., Tomei, C., Mutsaers, B., Secord, S., Power, J., Drummond, N., Hébert, M., & Wani, R. J.
- Affiliations
- McGill University (CA)
- University of Ottawa (CA)
- University Health Network (CA)
- York University (CA)
- Ottawa Hospital (CA)
- University of Waterloo (CA)
- Mount Sinai Hospital (CA)
- McGill University Health Centre (CA)
- Jewish General Hospital (CA)
- Université du Québec à Trois-Rivières (CA)
- ORCID
- Venue
- Health Psychology
- Published
- 2023-03
- Volume
- 42
- Issue
- 3
- Pages
- 182-194
- ISSN
- 0278-6133 (ISSN-L)
- 1930-7810
- OpenAlex
- W4322757424
- Cited by
- 43
- References
- 0
- Citations by year
- 2026: 15 · 2025: 19 · 2024: 5 · 2023: 4
- FWCI
- 5.44
- Type
- journal article
- Language
- en
- Update notices
- correction (2023-07-13)
- Open access
- hybrid
- doi.org
- Locations
- Health Psychology (publishedVersion, other-oa)
- PubMed (publishedVersion)
- Funders
- Réseau de recherche en interventions en sciences infirmières du Québec/Quebec Network on Nursing Interventions Research
- McGill University
- Canadian Cancer Society Research Institute (702589)
- Topics
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Childhood Cancer Survivors' Quality of Life
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- fear of cancer recurrence, breast cancer survivors, gynecologic cancer survivors, cancer-related distress, coping, cognitive avoidance, reassurance seeking, quality of life, booster sessions, psycho-oncology
- MeSH terms
- Cancer Survivors, Adaptation, Psychological, Fear, Female, Humans, Neoplasms, Phobic Disorders, Recurrence, Databases, Factual
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Fear of Cancer Recurrence Therapy (FORT): A Randomized Controlled Trial. https://app.cochat.ai/papers/10.1037/hea0001253
- The paper
- Maheu, C., Lebel, S., Bernstein, L. J., Courbasson, C., Singh, M., Ferguson, S. E., Harris, C., Jolicoeur, L., Baku, L., Muraca, L., Ramanakumar, A. V., Lamonde, F., Lefebvre, M., Tomei, C., Mutsaers, B., Secord, S., Power, J., Drummond, N., Hébert, M., & Wani, R. J. (2023). Fear of Cancer Recurrence Therapy (FORT): A Randomized Controlled Trial. Health Psychology. https://doi.org/10.1037/hea0001253
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.